Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence

Parkinsonism related to chronic Manganese exposure is notably due to focal lesions of the basal ganglia. Our study focused on epidemiological, clinical, toxicological and experimental aspects of Manganese-induced Parkinsonism in south of Morocco. It is a prospective study concerning the workers and...

Full description

Bibliographic Details
Main Authors: Najib Kissini, Yahya Naji, Yassine Mebrouk, Mohamed Chraa, Abderrazzak Ghanima
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Clinical Parkinsonism & Related Disorders
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590112520300256
id doaj-34c9c01d0b464a84be92d47fca3c7515
record_format Article
spelling doaj-34c9c01d0b464a84be92d47fca3c75152020-12-23T05:04:14ZengElsevierClinical Parkinsonism & Related Disorders2590-11252020-01-013100057Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidenceNajib Kissini0Yahya Naji1Yassine Mebrouk2Mohamed Chraa3Abderrazzak Ghanima4Clinical and Experimental Neuroscience Research Laboratory, Faculty of Medicine, Cadi Ayyad University, Marrakech, Morocco; Neurology department, University Teaching Hospital Mohammed VI, Marrakesh, Morocco; Corresponding author at: Neurology Department, University Hospital Mohamed VI, Marrakech, Morocco.Clinical and Experimental Neuroscience Research Laboratory, Faculty of Medicine, Cadi Ayyad University, Marrakech, MoroccoNeurology Department, University Hospital Mohammed VI, Oujda, MoroccoClinical and Experimental Neuroscience Research Laboratory, Faculty of Medicine, Cadi Ayyad University, Marrakech, MoroccoLaboratory of Bio-Organic and Macromolecular Chemistry, Department of Biology, Faculty of Sciences and Techniques, Marrakech, MoroccoParkinsonism related to chronic Manganese exposure is notably due to focal lesions of the basal ganglia. Our study focused on epidemiological, clinical, toxicological and experimental aspects of Manganese-induced Parkinsonism in south of Morocco. It is a prospective study concerning the workers and the residents bordering on the 2 mines in the south of Morocco. The results of the study concerned 120 cases divided into 4 groups of patients: G1: 30 cases exposed to different incriminated toxic products, which present Parkinsonian signs, G2: 30 cases healthy and exposed, G3: 30 cases affected with Idiopathic Parkinson's disease, and G4: 30 cases healthy and unexposed (controls).The results from the first mine show that 5.7% of the sample developed Manganese-Induced Parkinsonism and this percentage is slightly higher (4.5%) than the second mine site. Chemical and biological analysis revealed high levels of Manganese. The majority of patients did not improve the clinical signs under L-dopa treatment. The authors underline the gravity of Manganese-induced Parkinsonism and propose a listing of the various exposures as well as a cartography of the regions of risk in Morocco.http://www.sciencedirect.com/science/article/pii/S2590112520300256ParkinsonismManganeseChronic exposureToxicological samples
collection DOAJ
language English
format Article
sources DOAJ
author Najib Kissini
Yahya Naji
Yassine Mebrouk
Mohamed Chraa
Abderrazzak Ghanima
spellingShingle Najib Kissini
Yahya Naji
Yassine Mebrouk
Mohamed Chraa
Abderrazzak Ghanima
Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
Clinical Parkinsonism & Related Disorders
Parkinsonism
Manganese
Chronic exposure
Toxicological samples
author_facet Najib Kissini
Yahya Naji
Yassine Mebrouk
Mohamed Chraa
Abderrazzak Ghanima
author_sort Najib Kissini
title Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
title_short Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
title_full Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
title_fullStr Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
title_full_unstemmed Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
title_sort parkinsonism and chronic manganese exposure: pilot study with clinical, environmental and experimental evidence
publisher Elsevier
series Clinical Parkinsonism & Related Disorders
issn 2590-1125
publishDate 2020-01-01
description Parkinsonism related to chronic Manganese exposure is notably due to focal lesions of the basal ganglia. Our study focused on epidemiological, clinical, toxicological and experimental aspects of Manganese-induced Parkinsonism in south of Morocco. It is a prospective study concerning the workers and the residents bordering on the 2 mines in the south of Morocco. The results of the study concerned 120 cases divided into 4 groups of patients: G1: 30 cases exposed to different incriminated toxic products, which present Parkinsonian signs, G2: 30 cases healthy and exposed, G3: 30 cases affected with Idiopathic Parkinson's disease, and G4: 30 cases healthy and unexposed (controls).The results from the first mine show that 5.7% of the sample developed Manganese-Induced Parkinsonism and this percentage is slightly higher (4.5%) than the second mine site. Chemical and biological analysis revealed high levels of Manganese. The majority of patients did not improve the clinical signs under L-dopa treatment. The authors underline the gravity of Manganese-induced Parkinsonism and propose a listing of the various exposures as well as a cartography of the regions of risk in Morocco.
topic Parkinsonism
Manganese
Chronic exposure
Toxicological samples
url http://www.sciencedirect.com/science/article/pii/S2590112520300256
work_keys_str_mv AT najibkissini parkinsonismandchronicmanganeseexposurepilotstudywithclinicalenvironmentalandexperimentalevidence
AT yahyanaji parkinsonismandchronicmanganeseexposurepilotstudywithclinicalenvironmentalandexperimentalevidence
AT yassinemebrouk parkinsonismandchronicmanganeseexposurepilotstudywithclinicalenvironmentalandexperimentalevidence
AT mohamedchraa parkinsonismandchronicmanganeseexposurepilotstudywithclinicalenvironmentalandexperimentalevidence
AT abderrazzakghanima parkinsonismandchronicmanganeseexposurepilotstudywithclinicalenvironmentalandexperimentalevidence
_version_ 1724373127503282176